Faheem Hasnain Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 3 weeks ago
Faheem Hasnain has an estimated net worth of at least $12.1 million*, as of Oct. 29, 2025. They own 6.0 million shares of GOSS stock. They have sold 74,889 shares of GOSS stock since 2021, for an estimated $-2.1 million.
Faheem Hasnain $GOSS SEC Form 4 Insider Trading
Faheem Hasnain has filed a total of 7 insider trades in $GOSS since 2021. Their most recent trade was a purchase of 372,000 shares, made on Jun 21, 2024. Their largest trade was a purchase of 440,500 shares, made on Mar 22, 2023. We estimate that they now own 6.0 million shares of $GOSS, worth an estimated $14.1 million.
Insider Trading at $GOSS
There have been a total of 38 insider trades reported at $GOSS since 2021, with 1.9 million shares purchased and 149,072 shares sold. The most active insider traders in $GOSS stock have been Richard Aranda, Bryan Giraudo, and Faheem Hasnain. The most recent trade was a purchase of 26,050 shares reported by Sandra Milligan (None), made on Aug 19, 2025.
History of Insider Stock Trades by Faheem Hasnain
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
KURA
|
Sale | 10,000 | Dec 09, 2025 | Dec. 10, 2025, 5:05 p.m. |
|
KURA
|
Sale | 22,682 | Mar 21, 2025 | March 24, 2025, 4:33 p.m. |
GOSS
|
Purchase | 372,000 | Jun 21, 2024 | June 24, 2024, 5:52 p.m. |
|
GOSS
|
Sale | 23,172 | Mar 27, 2024 | March 28, 2024, 6:01 p.m. |
MRTX
|
Purchase | 10,791 | Aug 11, 2023 | Aug. 14, 2023, 4:41 p.m. |
|
GOSS
|
Purchase | 269,389 | Mar 21, 2023 | March 22, 2023, 5:14 p.m. |
|
GOSS
|
Purchase | 440,500 | Mar 22, 2023 | March 22, 2023, 5:14 p.m. |
|
GOSS
|
Purchase | 168,683 | Mar 20, 2023 | March 22, 2023, 5:14 p.m. |
|
GOSS
|
Purchase | 138,696 | Jul 15, 2022 | July 15, 2022, 4:21 p.m. |
|
GOSS
|
Sale | 19,035 | Mar 23, 2022 | March 24, 2022, 4:55 p.m. |
$GOSS Executives and Stock Owners with Insider Trades
-
Richard Aranda, Chief Medical Officer
-
Bryan Giraudo, COO/CFO
-
Faheem Hasnain, President & CEO
-
Laura Carter, Chief Scientific Officer
-
Caryn Peterson, EVP, Regulatory Affairs
-
Waage Christian, EVP, Tech Ops and Admin
-
Robert Paul Jr Smith, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.